Sunday, March 26th, 2017, 11:00-12:30
Hall 2, Palais des Congrès – Marseille Chanot
1956 – 2016: a long journey from the first successful BMT to the first successful patient-specific cell therapy in HSCT, approved by EC
Chairs Christian Chabannon - Head of Cell Therapy Facility at Institut Paoli-Calmettes (France)
Fabio Ciceri - Director of Hematology and BMT Unit, San Raffaele Scientific Institute (Italy)
Presentations
Christian Chabannon Introduction
Annalisa Ruggeri – Service d'Hématologie et Thérapie Cellulaire, Hôpital Saint-Antoine (France) Safe post-transplant donor lymphocytes infusion in the era of T-cell engineering
Attilio Bondanza – Head of Innovative Immunotherapies Unit, San Raffaele Scientific Institute (Italy) CAR T-cell immunotherapy beyond lymphoid malignancies
Giuliana Ferrari – Head of Gene Transfer Into Stem Cells Unit, SR-TIGET, San Raffaele Scientific Institute (Italy) Gene therapy for beta-thalassemia
The purpose of this symposium is to outline what could be breakthrough treatments in the promising field of immune-gene therapy, on the 60th anniversary from the first successful BMT.
